Harnal-D Tab.

DRUG2 trials

Sponsors

Chong Kun Dang Pharmaceutical

Conditions

Benign Prostatic Hyperplasia

Phase 1

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. Harnal-D in Healthy Volunteers

CompletedNCT03887858

Chong Kun Dang PharmaceuticalBenign Prostatic Hyperplasia

Start: 2019-03-11End: 2019-05-07Updated: 2020-01-30

Study to Evaluate the Bioequivalence of Astellas Phama Korea Inc. Harnal-D in Healthy Volunteers After Meal

CompletedNCT03887871

Chong Kun Dang PharmaceuticalBenign Prostatic Hyperplasia

Start: 2019-03-11End: 2019-04-23Updated: 2020-01-30